{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-services-scotland-amendment-regulations-2021/regulation-3",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-services-scotland-amendment-regulations-2021/regulation-3.json",
  "legislation": "ssi/2021/367",
  "legislation_title": "The National Health Service (Pharmaceutical Services) (Scotland) Amendment Regulations 2021",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-services-scotland-amendment-regulations-2021",
  "path": "regulation/3",
  "kind": "regulation",
  "number": "3",
  "heading": "Amendment of the National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009",
  "text": "In regulation 2(1) (interpretation and application) after the definition of “clinical management plan” insert—\n““collection and delivery arrangement” means an arrangement within the meaning of regulation 248(2) of the Human Medicines Regulations 2012,”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "S.I. 2012/1916. Relevantly amended by S.I. 2016/186 and S.I. 2018/199."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/ssi/2021/367/regulation/3",
    "retrieved_at": "2026-10-28T20:53:42.441447+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}